These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2626294)

  • 1. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
    Asensi F; Pérez-Tamarit D; Otero MC; Gallego M; Llanes S; Abadia C; Cantó E
    Pediatr Infect Dis J; 1989 Dec; 8(12):895. PubMed ID: 2626294
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus.
    Asensi F; Otero MC; Pérez-Tamarit D; Rodríguez-Escribano I; Cabedo JL; Gresa S; Cantón E
    J Chemother; 1993 Apr; 5(2):133-4. PubMed ID: 8515296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with imipenem-cilastatin in a girl with resistant pneumococcal meningitis].
    Tamayo López G; González Bravo N; Sánchez Bayle M
    An Esp Pediatr; 1993 Jul; 39(1):75. PubMed ID: 8363158
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of imipenem-cilastatin in neonatal meningitis caused by Citrobacter diversus.
    Haimi-Cohen Y; Amir J; Weinstock A; Varsano I
    Acta Paediatr; 1993; 82(6-7):530-2. PubMed ID: 8338984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs recently released in Belgium. Torasemide, nalbuphine, imipenem-cilastatin.
    Harvengt C
    Acta Clin Belg; 1987; 42(4):298-302. PubMed ID: 3270973
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
    Bonatti H; Guggenbichler JP; Hager J
    Infection; 1990; 18(5):302-6. PubMed ID: 2276826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipenem/cilastatin as secondary therapy for bacterial infections.
    Kono K; Onuki K; Tohara S; Takeda S
    Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin drug utilization evaluation in a large community hospital.
    Sesin GP
    DICP; 1991 Dec; 25(12):1399. PubMed ID: 1815448
    [No Abstract]   [Full Text] [Related]  

  • 11. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem-cilastatin monotherapy in severe infections accompanying hematological malignancies.
    Urabe A; Takaku F; Mizoguchi H
    Jpn J Med; 1991; 30(5):420-3. PubMed ID: 1803041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin (Primaxin): evaluation in general surgical practice.
    Chin MJ; Bagshaw PF; Bremner JM
    N Z Med J; 1991 Jan; 104(904):22-3. PubMed ID: 2008258
    [No Abstract]   [Full Text] [Related]  

  • 15. Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
    O'Riordan J; Javed M; Doherty C; Hutchinson M
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):383. PubMed ID: 8158196
    [No Abstract]   [Full Text] [Related]  

  • 16. Imipenem-cilastatin sodium.
    Roach AC
    Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800
    [No Abstract]   [Full Text] [Related]  

  • 17. Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.
    Ahonkhai VI; Cyhan GM; Wilson SE; Brown KR
    Pediatr Infect Dis J; 1989 Nov; 8(11):740-4. PubMed ID: 2687787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intra-abdominal infections using imipenem/cilastatin.
    Leaper D; Thomas W; Kennedy R; Leow C; Avery D
    Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with imipenem-cilastatin in intensive therapy].
    Verre M; D'Antona R; Macrina E
    Clin Ter; 1991 Feb; 136(4):273-8. PubMed ID: 1827390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin].
    Fiorentino F; De Sena R; Manzillo E; Iadanza A; Conte M; Coppola MG; Galderisi P; Postiglione A; Arciello MT; Covelli B
    Clin Ter; 1989 May; 129(4):287-91. PubMed ID: 2527122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.